Previdi, S., Malek, A., Albertini, V., Riva, C., Capella, C., Broggini, M., . . . Catapano, C. V. (2010). Inhibition of Sp1 dependent transcription and antitumor activity of the new aureolic acid analogues Mithramycin SDK and SK in human ovarian cancer xenografts.
Chicago Style CitationPrevidi, Sara, Anastasia Malek, Veronica Albertini, Cristina Riva, Carlo Capella, Massimo Broggini, Giuseppina M. Carbone, Jurgen Rohr, i Carlo V. Catapano. Inhibition of Sp1 Dependent Transcription and Antitumor Activity of the New Aureolic Acid Analogues Mithramycin SDK and SK in Human Ovarian Cancer Xenografts. 2010.
Cita MLAPrevidi, Sara, et al. Inhibition of Sp1 Dependent Transcription and Antitumor Activity of the New Aureolic Acid Analogues Mithramycin SDK and SK in Human Ovarian Cancer Xenografts. 2010.